These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36517095)

  • 1. Effectiveness of a training intervention in increasing the use of misoprostol in postabortion care in Malawi: a quasi-experimental study.
    Magreta Chakhame B; Darj E; Mwapasa M; Kafulafula U; Chiudzu G; Maluwa A; Malata A; Odland JØ; Odland ML
    BMJ Open; 2022 Dec; 12(12):e061886. PubMed ID: 36517095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care providers' perceptions of using misoprostol in the treatment of incomplete abortion in Malawi.
    Wagenheim CA; Savosnick H; Chakhame BM; Darj E; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
    BMC Health Serv Res; 2022 Dec; 22(1):1471. PubMed ID: 36461125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study.
    Chakhame BM; Darj E; Mwapasa M; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
    Reprod Health; 2023 Feb; 20(1):26. PubMed ID: 36732793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa.
    Dao B; Blum J; Thieba B; Raghavan S; Ouedraego M; Lankoande J; Winikoff B
    BJOG; 2007 Nov; 114(11):1368-75. PubMed ID: 17803715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya.
    Makenzius M; Oguttu M; Klingberg-Allvin M; Gemzell-Danielsson K; Odero TMA; Faxelid E
    BMJ Open; 2017 Oct; 7(10):e016157. PubMed ID: 29018067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating women's acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study.
    Atuhairwe S; Hanson C; Atuyambe L; Byamugisha J; Tumwesigye NM; Ssenyonga R; Gemzell-Danielsson K
    BMC Womens Health; 2022 Nov; 22(1):434. PubMed ID: 36335344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of Using Misoprostol in the Management of Incomplete Abortions: A Voice of Healthcare Workers in Central Malawi.
    Chakhame BM; Darj E; Mwapasa M; Kafulafula UK; Maluwa A; Chiudzu G; Malata A; Odland JØ; Odland ML
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
    Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary Contraceptive Uptake Among Postabortion Care Clients Treated With Misoprostol in Rwanda.
    Packer C; Pack AP; McCarraher DR
    Glob Health Sci Pract; 2019 Aug; 7(Suppl 2):S247-S257. PubMed ID: 31455622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing misoprostol for treatment of incomplete abortion: A feasibility and acceptability study in secondary-level health facilities in Myanmar.
    Mary M; Tin KN; Maung TM; Maung HN; Ku SK; Winikoff B
    Sex Reprod Healthc; 2023 Jun; 36():100825. PubMed ID: 36842188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage.
    Patua B; Dasgupta M; Bhattacharyya SK; Bhattacharya S; Hasan SH; Saha S
    Arch Gynecol Obstet; 2013 Dec; 288(6):1243-8. PubMed ID: 23708389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study.
    Ani VC; Enebe JT; Dim CC; Dim NR; Ozumba BC
    Pan Afr Med J; 2022; 41():90. PubMed ID: 35432695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
    Ortiz J; Blades N; Prada E
    Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial.
    Klingberg-Allvin M; Cleeve A; Atuhairwe S; Tumwesigye NM; Faxelid E; Byamugisha J; Gemzell-Danielsson K
    Lancet; 2015 Jun; 385(9985):2392-8. PubMed ID: 25817472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of misoprostol for the treatment of incomplete abortion beyond 12 weeks of pregnancy in Benin.
    Adisso S; Hounkpatin BI; Komongui GD; Sambieni O; Perrin RX
    Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S36-9. PubMed ID: 24800660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of incomplete abortion related to treatment modality.
    Sharvit M; Yagur Y; Shams R; Daykan Y; Klein Z; Schonman R
    Arch Gynecol Obstet; 2023 Nov; 308(5):1543-1548. PubMed ID: 37653249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.